Lobeline sulfate

General description Monoclonal Anti-Neurocan (mouse IgG1 isotype) is derived from the hybridoma 650.24 produced by the fusion of mouse myeloma cells (P3X cells) and splenocytes from BALB/c mice immunized with embryonic rat brain proteoglycans.

General description Monoclonal Anti-Neurocan (mouse IgG1 isotype) is derived from the hybridoma 650.24 produced by the fusion of mouse myeloma cells (P3X cells) and splenocytes from BALB/c mice immunized with embryonic rat brain proteoglycans.

Immunogen Synthetic peptide directed towards the middle region of human SGMS1 Biochem/physiol Actions SGMS1 is predicted to be a five-pass transmembrane protein. This gene may be predominately expressed in brain.

Specificity Spinophilin Immunogen Synthetic peptide from rat Spinophilin. Application Anti-Spinophilin Antibody detects level of Spinophilin &amp has been published &amp validated for use in WB.

&#946 Amyloid 1-42 is a derivative of integral membrane-bound amyloid precursor protein. It is the most important alloform of the Alzheimer&#8242s peptide.

BSc3094 is a Tau aggregation inhibitor. BSc3094 can be used for the research of Alzheimer's disease (AD)In VivoBSc3094 (3 mg/kg: i.v.) direct intraventricular administration reduces sarkosyl-insoluble Tau . BSc3094 (0.075~1.5 mM: intraventricular

BSc3094 is a Tau aggregation inhibitor. BSc3094 can be used for the research of Alzheimer's disease (AD)In VivoBSc3094 (3 mg/kg: i.v.) direct intraventricular administration reduces sarkosyl-insoluble Tau . BSc3094 (0.075~1.5 mM: intraventricular

BSc3094 is a Tau aggregation inhibitor. BSc3094 can be used for the research of Alzheimer's disease (AD)In VivoBSc3094 (3 mg/kg: i.v.) direct intraventricular administration reduces sarkosyl-insoluble Tau . BSc3094 (0.075~1.5 mM: intraventricular

BSc3094 is a Tau aggregation inhibitor. BSc3094 can be used for the research of Alzheimer's disease (AD)In VivoBSc3094 (3 mg/kg: i.v.) direct intraventricular administration reduces sarkosyl-insoluble Tau . BSc3094 (0.075~1.5 mM: intraventricular

It is the major structural phospholipid in the brain, comprising 20-25% of total lipids. It is primarily localized to gray matter.A major structural phospholipid in the brain.

It is the major structural phospholipid in the brain, comprising 20-25% of total lipids. It is primarily localized to gray matter.A major structural phospholipid in the brain.

Product Describtion:DPTIP is a potent brain penetrant neutral sphingomyelinase 2 (N-SMase 2) inhibitor (exosome inhibitor), with an IC50 of 30 nM。.